Pyxis Oncology: MICVO’s Emerging Clinical Profile and Strong Physician Receptivity Support Buy Rating and Unchanged $6 Price Target
at www.tipranks.com (Wed, 16-Sep 5:57 PM)
Pyxis Oncology Secures $114 Million Financing to Advance MICVO Trials—Cash Runway Now Extends to 2027
Market Chameleon (Tue, 30-Jun 10:32 AM)
